Publication Cover
Global Public Health
An International Journal for Research, Policy and Practice
Volume 15, 2020 - Issue 2
346
Views
1
CrossRef citations to date
0
Altmetric
Articles

The technological imperative in tuberculosis care and prevention in Vietnam

ORCID Icon, , &
Pages 307-320 | Received 12 May 2019, Accepted 11 Jul 2019, Published online: 17 Aug 2019

References

  • Ahlgren, I., Seiji, Y., & Wong, A. (2014). Rising oceans, climate change. Food Aid and Human Rights in the Marshall Islands. Health and Human Rights Journal, 16, 69–80.
  • Albert, H., Nathavitharana, R. R., Isaacs, C., Pai, M., Denkinger, C. M., & Boehme, C. C. (2016). Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: What lessons have we learnt and how can we do better? European Respiratory Journal, 48(2), 516–525. doi: 10.1183/13993003.00543-2016
  • Banta, H. D., & Thacker, S. B. (1979). Policies toward medical technology: The case of electronic fetal monitoring. American Journal of Public Health, 69, 931–935.
  • Bhargava, A., Madhukar, P., Bhargava, M., Marais, B. J., & Menzies, D. (2012). Can social interventions prevent tuberculosis?: The Papworth experiment (1918–1943) revisited. American Journal of Respiratory and Critical Care Medicine, 186(5), 442–449. doi: 10.1164/rccm.201201-0023OC
  • Boehme, C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., … Perkins, M. D. (2010). Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine, 363, 1005–1015. doi: 10.1056/NEJMoa0907847
  • Chandler, C. I., Hall-Clifford, R., Asaph, T., Pascal, M., Clarke, S., & Mbonye, A. K. (2011). Introducing malaria rapid diagnostic tests at registered drug shops in Uganda: Limitations of diagnostic testing in the reality of diagnosis. Social Science & Medicine, 72(6), 937–944.
  • Charurat, M., Emmanuel, B., Akolo, C., Keshinro, B., Nowak, R., Kennedy, S., … Blattner, W. (2015). Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. Journal of Acquired Immune Deficiency Syndromes, 68(Suppl 2), S114.
  • Coates, T. J., Richter, L., & Caceres, C. (2008). Behavioural strategies to reduce HIV transmission: How to make them work better. The Lancet, 372(9639), 669–684. doi: 10.1016/S0140-6736(08)60886-7
  • Cox, H., Dickson-Hall, L., Ndjeka, N., Grant, A., Van't Hoog, A., Stevens, W., … Nicol, M. (2015). The drug-resistant TB treatment gap and treatment initiation delays in South Africa: Impact of Xpert implementation. OA: 390–405. 46th Union World Conference on Lung Health, Cape Town.
  • Daniel, T. M. (2006). The history of tuberculosis. Respiratory Medicine, 100, 1862–1870. doi: 10.1016/j.rmed.2006.08.006
  • Daniels, M. (1949). Tuberculosis in Europe during and after the second world war. British Medical Journal, 2(4637), 1135–1140. doi: 10.1136/bmj.2.4636.1065
  • Dlamini-Mvelase, N. R., Werner, L., Phili, R., Cele, L. P., & Mlisana, K. P. (2014). Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa. BMC Infectious Diseases, 14(1), 1. doi: 10.1186/1471-2334-14-442
  • Dye, C., Knut, L., Jaramillo, E., Williams, B. G., & Raviglione, M. C. (2009). Trends in tuberculosis incidence and their determinants in 134 countries. Bulletin of the World Health Organisation, 87(9): 683–691.
  • Ecks, S., & Harper, I. (2013). Public-private mixes: The market for anti-tuberculosis drugs in India. In J. Biehl, & A. Petryna (Eds.), When people come first: Critical studies in global health (pp. 252–276). Durham, NC: Duke University Press.
  • Engel, N. (2015). Tuberculosis in India: A case of innovation and control. New Delhi: Orient Black Swan.
  • Evans, C. A. (2011). Genexpert—a game-changer for tuberculosis control? PLoS Medicine, 8(7), e1001064. doi: 10.1371/journal.pmed.1001064
  • Farmer, P. (2002). Social medicine and the challenge of biosocial research. In: Innovative Structures in Basic Research: Ringberg-Symposium 4-7 October 2000 (pp. 55–73). Munich, Germany: Generalverwaltung der Max-Planck-Gesellschaft, Referat Press-und Õffentlichkeitsarbeit.
  • Fitzpatrick, C., & Floyd, K. A. (2012). Systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics, 30(1), 63–80. doi:10.2165/11595340- 000000000-00000
  • Frieden, T. R. (2009). Lessons from tuberculosis control for public health. The International Journal of Tuberculosis and Lung Disease, 13(4), 421–428.
  • Fujita, M., Poudel, K. C., Thi, N. D., Duc, D. B., Van, K. N., Green, K., … Jimba, M. (2012). A new analytical framework of ‘continuum of prevention and care’ to maximize HIV case detection and retention in care in Vietnam. BMC Health Services Research, 12(1), 483.
  • Galagan, J. (2014). Genomic insights into tuberculosis. Nature Reviews Genetics, 15, 307–320. doi: 10.1038/nrg3664
  • Geiter, L. (Ed.). (2000). Ending neglect: The elimination of tuberculosis in the United States. Washington, DC: National Academies Press.
  • Gradmann, C. (2006). Robert Koch and the White death: From tuberculosis to tuberculin. Microbes and Infection, 8, 294–301.
  • Hargreaves, J. R., Boccia, D., Evans, C. A., Adato, M., Petticrew, M., & Porter, J. D. H. (2011). The social determinants of tuberculosis: From evidence to action. American Journal of Public Health, 101(4), 654–662. doi: 10.2105/AJPH.2010.199505
  • Hawgood, B. J. (2007). Albert Calmette (1863–1933) and Camille Guérin (1872–1961): the C and G of BCG vaccine. Journal of Medical Biography, 15, 139–146. doi: 10.1258/j.jmb.2007.06-15
  • Hoa, N. B., Sy, D. N., Nhung, N. V., Tiemersma, E. W., Borgdorffc, M. W., & Cobelens, F. G. J. (2010). National survey of tuberculosis prevalence in Viet Nam. Bulletin of the World Health Organization, 88, 273–280. doi: 10.2471/BLT.09.067801
  • Hoang, T. T. T., Nhung, V. N., Sy, N. D., Nguyen, H. B., Cobelens, F., Thwaites, G., … Wertheim, H. F. L. (2015). Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. BMC Public Health, 15, 980. doi: 10.1186/s12889-015-2338-5
  • Holloway, K. L., Staub, K., Rühli, F., & Henneberg, M. (2014). Lessons from history of socioeconomic improvements: A new approach to treating multi-drug-resistant tuberculosis. Journal of Biosocial Science, 46, 600–620. doi: 10.1017/S0021932013000527
  • Horn, T., Sherwood, J., Remien, RH, Nash, D, Auerbach, JD, & Treatment Action Group and Foundation for AIDS Research HIV Prevention Continuum Working Group. (2016). Towards an integrated primary and secondary HIV prevention continuum for the United States: A cyclical process model. Journal of the International AIDS Society, 19(1), 21263.
  • Houben, R. M., Menzies, N. A., Sumner, T., Huynh, G. H., Arinaminpathy, N., Goldhaber-Fiebert, J. D., … Suen, S. C. (2016). Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: A combined analysis of 11 mathematical models. The Lancet Global Health, 4(11), e806–e815. doi: 10.1016/S2214-109X(16)30199-1
  • Hung, N. V. (2013). GeneXpert implementation in Vietnam, 5th Global Laboratory Initiative meeting, France. 15-18 April 2013. Retrieved from http://www.who.int/tb/laboratory/gli-partners-meeting-5.pdf?ua=1
  • Kaufmann, S. H. E. (2003). A short history of Robert Koch's fight against tuberculosis: Those who do not remember the past are condemned to repeat it. Tuberculosis, 83, 86–90. doi: 10.1016/S1472-9792(02)00064-1
  • Kleinman, A., Das, V., & Lock, M. M. (Eds.). (1997). Social suffering. Berkeley: University of California Press.
  • Koch, E. (2013). Free market tuberculosis: Managing epidemics in post-Soviet Georgia. Nashville: Vanderbilt University Press.
  • Koenig, B. A. (1988). ‘The technological imperative in medical practice: The social Creation of a “routine” treatment.’. In M. Lock, & D. Gordon (Eds.), Biomedicine Examined. Culture, illness and Healing (Vol. 13, pp. 465–496). Dordrecht: Springer.
  • Lakoff, A. (2015). Real-time biopolitics: The actuary and the sentinel in global public health. Economy and Society, 44(1), 40–59. doi: 10.1080/03085147.2014.983833
  • Lincoln, M. (2014). Medical stratification in Vietnam. Medicine Anthropology Theory, 1(1), 21–33.
  • Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. C. (2009). Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Social Science & Medicine, 68, 2240–2246. doi: 10.1016/j.socscimed.2009.03.041
  • Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., De Vries, G., Diel, R., … Ochoa, E. R. (2015). Towards tuberculosis elimination: An action framework for low-incidence countries. European Respiratory Journal, 45(4), 928–952.
  • Lyttleton, C. (2018). Vigilance and sentinels in global health security. Medical Anthropology, 37(4), 327–342. doi: 10.1080/01459740.2017.1423071
  • Mandal, S., & Arinaminpathy, N. (2015). Transmission modeling and health systems: The case of TB in India. International Health, 7(2), 114–120.
  • Marks, G. B., Bai, J., Simpson, S. E., Sullivan, E. A., & Stewart, G. J. (2000). Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: Reappraising the estimates of risk. American Journal of Respiratory and Critical Care Medicine, 162(5), 1851–1854.
  • Mason, P. H., Fox, G., Ho, J., & Degeling, C. (2018). Cures, tuberculosis, and de-territorialized biomedical narratives. Public Culture, 30(2), 269–276.
  • Mason, P. H., Oni, T., van Herpen, M. M. J. W., & Coussens, A. K. (2016). TB prevention must integrate technological and basic care innovation. European Respiratory Journal, 48(5), 1529–1531.
  • Merton, R. K. (1936). The unanticipated consequences of purposive social action. American Sociological Review, 1, 894–904.
  • Meyer-Rath, G., Schnippel, K., Long, L., MacLeod, W., Sanne, I., Stevens, W., … Rosen, S. (2012). The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One, 7, e36966. doi: 10.1371/journal.pone.0036966
  • Murray, J. F. (2007). Historical development of tuberculosis since Robert Koch's discovery of the tubercle bacillus in 1882. Pneumologie, 61(12), 764–770.
  • Nader, L. (1972). Up the anthropologist: Perspectives gained from studying up. In D. Hymes (Ed.), Reinventing anthropology (pp. 285–311). New York: Pantheon Press.
  • O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013). The immune response in tuberculosis. Annual Review of Immunology, 31, 475–527. doi: 10.1146/annurev-immunol-032712-095939
  • Oxlade, O., Schwartzman, K., Behr, M. A., Benedetti, A., Pai, M., Heymann, J., & Menzies, D. (2009). Global tuberculosis trends: A reflection of changes in tuberculosis control or in population health? International Journal of Tuberculosis and Lung Disease, 13(10), 1238–1246.
  • Packard, R. M. (1989). White plague, black labor: Tuberculosis and the political economy of health and disease in South Africa. Berkeley and Los Angeles: University of California Press.
  • Paluzzi, J. E. (2004). A social disease/a social response: Lessons in tuberculosis from early 20th century Chile. Social Science and Medicine, 59, 763–773. doi: 10.1016/j.socscimed.2003.11.039
  • Panter-Brick, C., Eggerman, M., & Tomlinson, M. (2014). How might global health master deadly sins and strive for greater virtues? Global Health Action, 7. doi: 10.3402/gha.v7.23411
  • Philipsen, R. H. H. M., Sánchez, C. I., Maduskar, P., Melendez, J., Peters-Bax, L., Peter, J. G., … van Ginneken, B. (2015). Automated chest-radiography as a triage for Xpert testing in resource-constrained settings: A prospective study of diagnostic accuracy and costs. Scientific Reports, 5, 12215. doi: 10.1038/srep12215
  • Pringle, P. (2012). Experiment eleven: Deceit and betrayal in the discovery of the cure for tuberculosis. London, UK: Bloomsbury.
  • Qin, Z. Z., Pai, M., Van Gemert, W., Sahu, S., Ghiasi, M., & Creswell, J. (2014). How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? European Respiratory Journal. doi: 10.1183/09031936.00147714
  • Rasanathan, K., Kurup, A. S., Jaramillo, E., & Lönnroth, K. (2011). The social determinants of health: Key to global tuberculosis control. The International Journal of Tuberculosis and Lung Disease, 15(Supplement 2), S30–S36. doi: 10.5588/ijtld.10.0691
  • Sakula, A. (1992). Robert Koch: Centenary of the discovery of the tubercle bacillus, 1882. Thorax, 37(4), 246–251.
  • Schumacher, S. G., Sohn, H., Qin, Z. Z., Gore, G., Davis, J. L., Denkinger, C. M., & Pai, M. (2016). Impact of molecular diagnostics for tuberculosis on patient-important outcomes: A systematic review of study methodologies. PLoS One, 11, e0151073. doi: 10.1371/journal.pone.0151073
  • Schumacher, S. G., Thangakunam, B., Denkinger, C. M., Oliver, A. A., Shakti, K. B., Qin, Z. Z., … Christopher, D. J. (2015). Impact of point-of-care implementation of Xpert(R) MTB/RIF: Product vs. process innovation. International Journal of Tuberculosis and Lung Disease, 19, 1084–1090. doi: 10.5588/ijtld.15.0120
  • Shapiro, M. F., & Shapiro, S. (1987). Apheresis in renal transplantation and chronic inflammatory demyelinating polyneuropathy: Case studies in the evolution of enthusiasm for a technology. International Journal of Technology Assessment in Health Care, 3, 148–171.
  • Sharma, A., Hill, A., Kurbatova, E., van der Walt, M., Kvasnovsky, C., Tupasi, T. E., … Global Preserving Effective TB Treatment Study Investigators. (2017). Estimating the future burden of multidrug- resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: A mathematical modelling study. The Lancet Infectious Diseases, 17(7), 707–715. doi: 10.1016/S1473-3099(17)30247-5
  • Stone, R. (2013). Public enemy number one. Science, 340(6131), 422–425.
  • Street, A. (2018). Deep diagnostics. Limn, 9. Retrieved from https://limn.it/articles/deep-diagnostics/
  • Styblo, K. (1982). The number of cases of tuberculosis throughout the world has increased over the last 30 years. WHO/IUAT Information Kit. Geneva, Switzerland: WHO.
  • Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., … Dowdy, D. (2014). Feasibility, accuracy, and clinical effect of point-of- care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: A multicentre, randomised, controlled trial. The Lancet, 383(9915), 424–435. doi: 10.1016/S0140-6736(13)62073-5
  • Toungoussova, O. S., Bjune, G., & Caugant, D. A. (2006). Epidemic of tuberculosis in the former Soviet Union: Social and biological reasons. Tuberculosis, 86, 1–10. doi: 10.1016/j.tube.2005.04.001
  • Trinh, Q. M., Nguyen, H. L., Do, T. N., Nguyen, V. N., Nguyen, B. H., Nguyen, T. V. A., … Marais, B. J. (2016). Tuberculosis and HIV co-infection in Vietnam. International Journal of Infectious Diseases, 46, 56–60.
  • USAID. (2013). TB CARE - Year 2 Annual Report. Retrieved from http://tbcare2.org/cp-vietnam
  • Weatherall, M. (1990). In search of a cure: A history of pharmaceutical discovery. New York: Oxford University Press.
  • World Health Organization. (2011). Rapid implementation of the Xpert MTB/RIF diagnostic test. Geneva: WHO.
  • World Health Organization. (2012). Tuberculosis diagnostics Xpert MTB/RIF test. WHO Recommendations. Retrieved from http://www.who.int/tb/features_archive/factsheet_xpert.pdf
  • World Health Organization. (2013). Systematic screening for active tuberculosis: Principles and recommendations. Geneva: WHO.
  • World Health Organization. (2015a). Country cooperation strategy.Retrieved from http://www.who.int/countries/en/
  • World Health Organization. (2015b). Global tuberculosis Report 2015. Geneva: WHO.
  • World Health Organization. (2016). WHO treatment guidelines for drug-resistant tuberculosis - 2016 update. Geneva: WHO.
  • Yamada, S., Riklon, S., & Maskarinec, G. G. (2016). Ethical responsibility for the social production of tuberculosis. Journal of Bioethical Inquiry, 13(1), 57–64. doi:10.1007/s11673-015- 9681-1
  • Zvonareva, O., van Bergen, W., Kabanets, N., Alliluyev, A., & Filinyuk, O. (2018). Experiencing syndemic: Disentangling the biosocial complexity of tuberculosis through qualitative research. Journal of Biosocial Science, 1–5. doi: 10.1017/S0021932018000263

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.